Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-steroidal anti-inflammatory drugs and platelet function.

E G McQueen, B Facoory, J M Faed

    The New Zealand Medical Journal
    |May 28, 1986
    PubMed
    Summary

    Newer non-steroidal anti-inflammatory drugs (NSAIDs) affect platelet function. Short-acting NSAIDs showed temporary effects on cyclooxygenase activity, while aspirin and long-acting NSAIDs like piroxicam had prolonged impacts on platelet malondialdehyde production.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Results of Hypotensive Therapy in Arterial Hypertension.

    British medical journal·2010
    Same author

    Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin lambda light chain.

    Haematologica·2007
    Same author

    Dietary iron intakes and biochemical iron status of 15-49 year old women in New Zealand: is there a cause for concern?

    The New Zealand medical journal·2001
    Same author

    Hypofibrinogenemia in an individual with 2 coding (gamma82 A-->G and Bbeta235 P-->L) and 2 noncoding mutations.

    Blood·2000
    Same author

    Rapid identification of an A1555G mutation in human mitochondrial DNA implicated in aminoglycoside-induced ototoxicity.

    Journal of human genetics·1999
    Same author

    The frequency in New Zealand of a mitochondrial DNA mutation (1555 A to G) associated with aminoglycoside-induced hearing loss.

    The New Zealand medical journal·1999

    Area of Science:

    • Pharmacology
    • Biochemistry
    • Hematology

    Background:

    • Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
    • Platelet function is crucial for hemostasis and thrombosis.
    • Cyclooxygenase (COX) activity in platelets can be assessed by measuring malondialdehyde (MDA) production.

    Purpose of the Study:

    • To evaluate the impact of newer NSAIDs on platelet function.
    • To compare the duration of action of different NSAIDs on platelet COX activity.

    Main Methods:

    • Platelet-rich plasma was isolated from healthy volunteers.
    • Malondialdehyde (MDA) production was measured as an indicator of cyclooxygenase (COX) activity.
    • The effects of single doses of diflunisal, naproxen, sulindac, aspirin, and piroxicam were assessed at various time points (1, 3, 24, 48, and 72 hours).

    Main Results:

    • Short-acting NSAIDs (diflunisal, naproxen, sulindac) significantly reduced MDA production within hours, with recovery by 48 hours.
    • Aspirin caused a marked reduction in MDA production that persisted for at least 72 hours.
    • The long-acting NSAID piroxicam also demonstrated a sustained inhibition of MDA production at 72 hours.

    Conclusions:

    • The duration of platelet inhibition varies significantly among different NSAIDs.
    • Aspirin and long-acting NSAIDs like piroxicam exhibit prolonged effects on platelet cyclooxygenase activity compared to short-acting NSAIDs.
    • These findings have implications for understanding the antiplatelet effects and potential risks associated with NSAID use.

    Related Experiment Videos